COVID-19 Immunity From mRNA Booster Does Not Last Very Long.

Study finds that the median length for the antibody half-life immune response was 63 days for the primary series, and increased to...

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

Adding Asia Broadband (AABB) to Speculative Watch List.

Asia Broadband, Gold Play With Digital Currency (NFT) Twist The last speculative stock trading under $0.05, that we...

GeoVax to Present at World Vaccine Congress, Thursday April 4th.

Chief Scientific Officer, Mark Newman, PhD, will present data on GEO-CM04S1, the Company’s next-generation non-MRNA Covid-19 vaccine...

Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...

Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. Altamira is developing and supplying peptide-based...

IMAC Holdings (BACK) Explodes 94% Higher Post Reverse Split, With 42 Million Shares Trading...

Simply Incredible! 2024 Will be the Year of Post Reverse Split Revenge! Taking advantage of post reverse-split investor...

China Remains at Risk to Future MonkeyPox Outbreaks.

GeoVax (GOVX) intends to become the first U.S.-based supplier of the MVA vaccine to prevent Mpox and smallpox.

GeoVax Live Webcast

Tonight, Monday at 5:30 PM. And You Don't Fly to Newport Beach and Deal With all the Drinking, Investment Bankers, and...

Latest article

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...

Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...